NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

Negotiations for wider availability of suboxone in ‘advanced stages’

By Mindo - 24th Apr 2018

This is a slight increase on the 109 people who were in receipt of suboxone at the end of December.

Suboxone is an alternative substitution treatment for opioid drug dependence and the HSE told the <strong><em>Medical Independent</em></strong> (<strong><em>MI</em></strong>) that it is currently available in 15 different clinics in the country and from “five level 2 GPs”.

However, the Executive spokesperson told <strong><em>MI</em></strong> that it is in the “advanced stages” of negotiations that should allow for the much wider distribution of suboxone across the country.

“The legislation has been enacted and the HSE are in advanced stages of negotiation with the company around pricing arrangements to allow wider availability of the product in the coming months,” the spokesperson told <strong><em>MI</em></strong>.

Separately, the HSE told <strong><em>MI</em></strong> that there were 9,717 people in receipt of methadone through the public health services at the end of February. This figure was up from 9,664 at the end of January, and 9,695 at the end of December 2017.

Currently, the majority of suboxone patients are receiving treatment in Dublin in over a dozen different clinics. In 2015, the Opioid Substitution Implementation Group recommended a phased increased access to buprenorphine [suboxone] products, subject to legislation being introduced and funding being made available.

Minister of State for Health Promotion and the National Drugs Strategy Catherine Byrne told the Dáil last October that “an additional €750,000 has been allocated to the HSE to facilitate the phased increase in the use of suboxone”.

Leave a Reply

Latest Issue
The Medical Independent 26th September 2023

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read